EKEléonore Kafando

Eléonore Kafando

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Eléonore Kafando has a total of 34 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Use of hydroxyurea in French-speaking Sub-Saharan Africa

    by Jean-Benoît Arlet, Françoise Bernaudin, Indou Deme-Ly, Binta Coulibaly, Anne Corbasson, Ibrahima Diagne, Dapa Diallo, Saliou Diop, Charlotte Eposse, Frédéric Galacteros, et al.

    The hydroxyurea is a save, affordable and essential medicine for sickle cell disease (SCD), reducing painful crises and mortality. To foster the prescription of hydroxyurea for patients with SCD in sub-Saharan African countries, the scientific advisory board of Drep.Afrique, a non-governmental organization dedicated to SCD in Africa, has developed a therapeutic guideline well suited to conditions on the ground. These guidelines answer three essential questions: which patients should be prioritized for treatment with hydroxyurea, which dose should be used, and what follow-up should be implemented in those low-resources countries? The guidelines are given as in a concise document for easy use by practitioners on the ground, available in English and in French.


    • 19 August 2023
      • Vol. 3  (3)
    Open Access

    [Prognostic factors and survival in adult acute leukemia in Burkina Faso].

    by Catherine Traoré, Koumpingnin Nebié, Salam Sawadogo, Adjaratou Fabienne Sanou, Arsène Héma, Éléonore Kafando

    Acute leukemia is both a diagnostic and therapeutic emergency. Our study aimed to describe the prognostic factors and survival of adults with acute leukemia in Burkina Faso. Cross-sectional descriptive study with retrospective data collection covering a period of 4.5 years (2018-2022) in two university hospitals in Burkina Faso. Were included all patients over 18 years hospitalized for acute leukemia in these sites with a usable medical record. A total of 42 cases were collected, of which 45% suffered from acute lymphoblastic leukemia and 43% from acute myeloid leukemia. In 12% of cases, acute leukemia was not classified. The average age was 35 ± 15 years, with extremes of 19 and 72 years. 12% of the patients presented an age of poor prognosis. Comorbidities were present in 14% of patients. The deterioration in general condition was fairly constant with 95% of patients at WHO stages 3 and 4. All patients presented with bone marrow failure syndrome and tumor syndrome was found in 45%. Anemia and thrombocytopenia were present in almost all cases. Hyperleukocytosis at diagnosis was present in 28 patients (67%); among them 18 patients (64%) had leukocytes greater than 50 G/L. Death in hospital was found in 38% of patients and loss of sight in 31%. The median survival was 3 months. Survival was 30% at 6 months and 0% at 12 months. Acute leukemias are in our practice conditions of poor prognosis with a fairly short survival.

  • Open Access

    Improving Blood Transfusion Safety: A Survey on the Knowledge and Attitudes of Health Professionals in Blood Transfusion at the Yalgado Ouedraogo University Hospital Center, Burkina Faso

    by Kafando Eléonore

    Introduction: National guidelines for best transfusion practices have been disseminated so that their recommendations can be applied to any health facility. This work was part of the approach to promoting transfusion safety. Its objective was to study the knowledge and attitudes of the clinical healthcare professionals in the Yalgado Ouédraogo University Hospital in the field of blood transfusion. Materials and methods: The survey-type study was conducted in four clinical departments of the Yalgado Ouédraogo University Hospital Center based on a questionnaire. It involved professionals practicing blood transfusion. The anonymous questionnaire was filled out by the participants themselves. There were multiplechoice questions and open-ended questions. Results: The participation rate was 64% (192/300). The respondents had an average of 7years of professional practice and worked in departments such as gynecology and obstetrics, pediatrics, nephrology and medical emergencies respectively in 48%, 26%, 16% and 10% of the cases. The study showed that transfusion therapy is a daily practice in clinical departments. However, knowledge is insufficient and compliance with transfusion best practices is limited. Conclusion: In order to sensitize health professionals on the particular issue of blood transfusion and to improve their knowledge/skills, continuous training of health workers involved in blood transfusion should be an integral part of the action plans of the medical facilities.


  • Open Access

    Incompatible blood transfusion in children in Burkina Faso

    by Eléonore Kafando, Lady Rosny Wandji Nana, Yacouba Domo, Yacouba Nébié, Dorcas Obiri-Yeboah, Jacques Simporé, Burkina Faso Hôpital Universitaire Pédiatrique Charles de Gaulle 01 Bp1198 Ouagadougou

    Incompatible blood transfusion in children in Burkina Faso


  • Neonatal haemoglobinopathy screening in Burkina Faso: Table 1

    by E Kafando, E Nacoulma, Y Ouattara, J Ayéroué, F Cotton, M Sawadogo, B Gulbis

    Aims: To report our experience of neonatal screening for sickle cell disease in Ouagadougou (Burkina Faso) and to discuss the feasibility of neonatal screening in this country. Methods: Between the years 2000 and 2004, there were about 2341 births in five maternity services in Ouagadougou. These babies were screened for sickle cell disease in a universal screening pilot programme. In 2006, 53 babies born to selected couples were screened. The specimens were collected either by cord blood sampling or from a dried blood spot on filter paper. The screening was performed using an isoelectric focusing technique. Results: In the first stage (2000–4), the incidence of sickle cell disease was 1:57. In the second stage, six of 53 babies of selected couples were found to have major haemoglobinopathies: one was homozygous for haemoglobin S and five were compound heterozygotes for haemoglobins S and C. Conclusions: The results suggest that a national screening programme should be implemented in Burkina Faso with effective newborn and subsequent follow-up, but a methodology needs to be developed.